{"pmid":32414230,"title":"Gynecological prevention and control model based on ward rearrangement and zoning management in pandemic period of COVID-19.","text":["Gynecological prevention and control model based on ward rearrangement and zoning management in pandemic period of COVID-19.","By 25th April 2020, the outbreak of COVID-19 caused 2719897 confirmed cases and 187705 deaths globally, remarkably more than Severe Acute Respiratory Syndrome (SARS) (8273 cases, 775 deaths) and Middle East Respiratory Syndrome (MERS) (1139 cases, 431 deaths) in 2003 and 2013, respectively. Gynecology is a specialty department with a large number of critical and severe patients. Consequently, it is of preeminent importance to formulate the in-patient management process. Rearranging the gynecological wards and managing ward partition, as well as the medical protection measures in specialized areas, are suitable for the current prevention and control for COVID-19 pandemic and the therapeutic requirements of patients. To effectively minimize nosocomial infections during the COVID- 19 pandemic period, our department implemented a novel prevention strategy based on the ward redesign and partition management. With this model, our department effectively protected the safety and health of patients and medical care staff from cross and nosocomial infection in the hospital. Now we would like to share the experience and strategies we implemented as following.","Panminerva Med","Liu, Jin","Yang, Jiang","Li, Suting","Chen, Jue","Yang, Lian","Zhao, Zhihan","Hong, Li","32414230"],"abstract":["By 25th April 2020, the outbreak of COVID-19 caused 2719897 confirmed cases and 187705 deaths globally, remarkably more than Severe Acute Respiratory Syndrome (SARS) (8273 cases, 775 deaths) and Middle East Respiratory Syndrome (MERS) (1139 cases, 431 deaths) in 2003 and 2013, respectively. Gynecology is a specialty department with a large number of critical and severe patients. Consequently, it is of preeminent importance to formulate the in-patient management process. Rearranging the gynecological wards and managing ward partition, as well as the medical protection measures in specialized areas, are suitable for the current prevention and control for COVID-19 pandemic and the therapeutic requirements of patients. To effectively minimize nosocomial infections during the COVID- 19 pandemic period, our department implemented a novel prevention strategy based on the ward redesign and partition management. With this model, our department effectively protected the safety and health of patients and medical care staff from cross and nosocomial infection in the hospital. Now we would like to share the experience and strategies we implemented as following."],"journal":"Panminerva Med","authors":["Liu, Jin","Yang, Jiang","Li, Suting","Chen, Jue","Yang, Lian","Zhao, Zhihan","Hong, Li"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32414230","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.23736/S0031-0808.20.03938-5","topics":["Prevention"],"weight":1,"_version_":1666994545876795392,"score":9.490897,"similar":[{"pmid":32134116,"title":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.","text":["Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.","By 27 February 2020, the outbreak of coronavirus disease 2019 (COVID-19) caused 82 623 confirmed cases and 2858 deaths globally, more than severe acute respiratory syndrome (SARS) (8273 cases, 775 deaths) and Middle East respiratory syndrome (MERS) (1139 cases, 431 deaths) caused in 2003 and 2013, respectively. COVID-19 has spread to 46 countries internationally. Total fatality rate of COVID-19 is estimated at 3.46% by far based on published data from the Chinese Center for Disease Control and Prevention (China CDC). Average incubation period of COVID-19 is around 6.4 days, ranges from 0 to 24 days. The basic reproductive number (R0 ) of COVID-19 ranges from 2 to 3.5 at the early phase regardless of different prediction models, which is higher than SARS and MERS. A study from China CDC showed majority of patients (80.9%) were considered asymptomatic or mild pneumonia but released large amounts of viruses at the early phase of infection, which posed enormous challenges for containing the spread of COVID-19. Nosocomial transmission was another severe problem. A total of 3019 health workers were infected by 12 February 2020, which accounted for 3.83% of total number of infections, and extremely burdened the health system, especially in Wuhan. Limited epidemiological and clinical data suggest that the disease spectrum of COVID-19 may differ from SARS or MERS. We summarize latest literatures on genetic, epidemiological, and clinical features of COVID-19 in comparison to SARS and MERS and emphasize special measures on diagnosis and potential interventions. This review will improve our understanding of the unique features of COVID-19 and enhance our control measures in the future.","J Med Virol","Wang, Yixuan","Wang, Yuyi","Chen, Yan","Qin, Qingsong","32134116"],"abstract":["By 27 February 2020, the outbreak of coronavirus disease 2019 (COVID-19) caused 82 623 confirmed cases and 2858 deaths globally, more than severe acute respiratory syndrome (SARS) (8273 cases, 775 deaths) and Middle East respiratory syndrome (MERS) (1139 cases, 431 deaths) caused in 2003 and 2013, respectively. COVID-19 has spread to 46 countries internationally. Total fatality rate of COVID-19 is estimated at 3.46% by far based on published data from the Chinese Center for Disease Control and Prevention (China CDC). Average incubation period of COVID-19 is around 6.4 days, ranges from 0 to 24 days. The basic reproductive number (R0 ) of COVID-19 ranges from 2 to 3.5 at the early phase regardless of different prediction models, which is higher than SARS and MERS. A study from China CDC showed majority of patients (80.9%) were considered asymptomatic or mild pneumonia but released large amounts of viruses at the early phase of infection, which posed enormous challenges for containing the spread of COVID-19. Nosocomial transmission was another severe problem. A total of 3019 health workers were infected by 12 February 2020, which accounted for 3.83% of total number of infections, and extremely burdened the health system, especially in Wuhan. Limited epidemiological and clinical data suggest that the disease spectrum of COVID-19 may differ from SARS or MERS. We summarize latest literatures on genetic, epidemiological, and clinical features of COVID-19 in comparison to SARS and MERS and emphasize special measures on diagnosis and potential interventions. This review will improve our understanding of the unique features of COVID-19 and enhance our control measures in the future."],"journal":"J Med Virol","authors":["Wang, Yixuan","Wang, Yuyi","Chen, Yan","Qin, Qingsong"],"date":"2020-03-06T11:00:00Z","year":2020,"_id":"32134116","source":"PubMed","week":"202010|Mar 02 - Mar 08","doi":"10.1002/jmv.25748","keywords":["covid-19","diagnosis and interventions","features"],"locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Prevention","Transmission","Diagnosis"],"weight":1,"_version_":1666138490711048192,"score":330.99994},{"pmid":32458596,"title":"Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists.","text":["Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists.","The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted Recommendations on Management of Gynecological Malignancies during the COVID-19 Pandemic based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients.","J Gynecol Oncol","Wang, Yingmei","Zhang, Shiqian","Wei, Lihui","Lin, Zhongqiu","Wang, Xinyu","Wang, Jianliu","Hua, Keqin","Cui, Manhua","Wang, Jiandong","Wang, Shixuan","Di, Wen","Wang, Yudong","An, Ruifang","Xi, Mingrong","Guo, Ruixia","Zhou, Qi","Xie, Xing","Xue, Fengxia","32458596"],"abstract":["The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted Recommendations on Management of Gynecological Malignancies during the COVID-19 Pandemic based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients."],"journal":"J Gynecol Oncol","authors":["Wang, Yingmei","Zhang, Shiqian","Wei, Lihui","Lin, Zhongqiu","Wang, Xinyu","Wang, Jianliu","Hua, Keqin","Cui, Manhua","Wang, Jiandong","Wang, Shixuan","Di, Wen","Wang, Yudong","An, Ruifang","Xi, Mingrong","Guo, Ruixia","Zhou, Qi","Xie, Xing","Xue, Fengxia"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458596","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3802/jgo.2020.31.e68","keywords":["covid-19","gynecological malignancies","management","pandemic","recommendations"],"locations":["China","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1668141322609885184,"score":217.00742},{"pmid":32416154,"title":"Management of Gynecology Patients during COVID-19 Pandemic: Chinese Expert Consensus.","text":["Management of Gynecology Patients during COVID-19 Pandemic: Chinese Expert Consensus.","Since December 2019, the outbreak of novel coronavirus disease 2019 (COVID-19) became a major epidemic threat in China and later spread worldwide. During the COVID-19 outbreak in mainland China, the Chinese Obstetricians and Gynecologists Association (COGA) distributed guidelines regarding care of gynecologic patients. These guidelines were developed by the Obstetrics and Gynecology department at Peking Union Medical College Hospital (PUMCH) and represent an effort to integrate infection control strategy and promote professionalism in medical practice. The guidelines represent collaboration with experts from 31 provinces and autonomous regions of mainland China over 2 weeks' time. With the implementation of these guidelines no nosocomial infections of COVID-19 have been identified at PUMCH. We think these guidelines might be helpful to departments of obstetrics and gynecology internationally during these unprecedented times. In our guidelines, we describe basic infection precaution principles, an epidemiologic screening tool, prioritization of surgical procedures, and operating room requirements. Using these principles, we then review management of gynecologic patients during the COVID-19 epidemic in the outpatient and operative and non-operative inpatient settings, as well as in clinical trials.","Am J Obstet Gynecol","Qiu, Lin","Morse, Abraham","Di, Wen","Song, Lei","Kong, Beihua","Wang, Zehua","Lang, Jinghe","Chai, Wenzhao","Zhu, Lan","32416154"],"abstract":["Since December 2019, the outbreak of novel coronavirus disease 2019 (COVID-19) became a major epidemic threat in China and later spread worldwide. During the COVID-19 outbreak in mainland China, the Chinese Obstetricians and Gynecologists Association (COGA) distributed guidelines regarding care of gynecologic patients. These guidelines were developed by the Obstetrics and Gynecology department at Peking Union Medical College Hospital (PUMCH) and represent an effort to integrate infection control strategy and promote professionalism in medical practice. The guidelines represent collaboration with experts from 31 provinces and autonomous regions of mainland China over 2 weeks' time. With the implementation of these guidelines no nosocomial infections of COVID-19 have been identified at PUMCH. We think these guidelines might be helpful to departments of obstetrics and gynecology internationally during these unprecedented times. In our guidelines, we describe basic infection precaution principles, an epidemiologic screening tool, prioritization of surgical procedures, and operating room requirements. Using these principles, we then review management of gynecologic patients during the COVID-19 epidemic in the outpatient and operative and non-operative inpatient settings, as well as in clinical trials."],"journal":"Am J Obstet Gynecol","authors":["Qiu, Lin","Morse, Abraham","Di, Wen","Song, Lei","Kong, Beihua","Wang, Zehua","Lang, Jinghe","Chai, Wenzhao","Zhu, Lan"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416154","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ajog.2020.05.024","keywords":["covid-19","sars-cov-2","coronavirus","gynecology"],"locations":["China","China","Chinese","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666994545849532416,"score":211.54794},{"pmid":32259322,"title":"Clinical Characteristics of COVID-19 After Gynecologic Oncology Surgery in Three Women: A Retrospective Review of Medical Records.","text":["Clinical Characteristics of COVID-19 After Gynecologic Oncology Surgery in Three Women: A Retrospective Review of Medical Records.","From a large medical center in Wuhan, the epicenter of the 2019 novel coronavirus disease (COVID-19), we report clinical features and prognosis for three women diagnosed with COVID-19 after gynecologic oncology surgery and hospitalized in January 2020. The incidence of COVID-19 was 0.77% (3 of 389) of total hospitalizations and 1.59% (3 of 189) of patients undergoing surgeries in the ward. The infection of severe acute respiratory syndrome coronavirus 2 may be related to the older age, comorbidities, malignant tumor, and surgery in gynecologic hospitalizations. By February 20, 2020, only two of the three patients had met the clinical discharge criteria. Given the long and uncertain incubation period of COVID-19, screening for the virus infection should be carried out for all patients, both preoperatively and postoperatively. Postponement of scheduled gynecologic surgery for patients in the epidemic area should be considered.","Oncologist","Yang, Shouhua","Zhang, Yuan","Cai, Jing","Wang, Zehua","32259322"],"abstract":["From a large medical center in Wuhan, the epicenter of the 2019 novel coronavirus disease (COVID-19), we report clinical features and prognosis for three women diagnosed with COVID-19 after gynecologic oncology surgery and hospitalized in January 2020. The incidence of COVID-19 was 0.77% (3 of 389) of total hospitalizations and 1.59% (3 of 189) of patients undergoing surgeries in the ward. The infection of severe acute respiratory syndrome coronavirus 2 may be related to the older age, comorbidities, malignant tumor, and surgery in gynecologic hospitalizations. By February 20, 2020, only two of the three patients had met the clinical discharge criteria. Given the long and uncertain incubation period of COVID-19, screening for the virus infection should be carried out for all patients, both preoperatively and postoperatively. Postponement of scheduled gynecologic surgery for patients in the epidemic area should be considered."],"journal":"Oncologist","authors":["Yang, Shouhua","Zhang, Yuan","Cai, Jing","Wang, Zehua"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259322","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1634/theoncologist.2020-0157","locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138493094461441,"score":208.07811},{"pmid":32077677,"title":"[Management strategy of Novel coronavirus pneumonia in burn and wound care ward].","text":["[Management strategy of Novel coronavirus pneumonia in burn and wound care ward].","The prevention and control of novel coronavirus pneumonia (NCP) has already entered a key period . The patients treated in the burn and wound care ward are susceptible to viral infection because of disease, age and other factors, so it is very important to manage the burn and wound care ward during the prevention and control of NCP epidemic. In this paper, combining with the key clinical problems of prevention and control in hospital during the epidemic period of NCP infection, medical evidence, and clinical and management experience, the author formulates prevention and control management strategy of the author's unit in order to provide reference for prevention and control of burn and wound care ward.","Zhonghua Shao Shang Za Zhi","Li, N","Liu, T M","Chen, H L","Liao, J M","32077677"],"abstract":["The prevention and control of novel coronavirus pneumonia (NCP) has already entered a key period . The patients treated in the burn and wound care ward are susceptible to viral infection because of disease, age and other factors, so it is very important to manage the burn and wound care ward during the prevention and control of NCP epidemic. In this paper, combining with the key clinical problems of prevention and control in hospital during the epidemic period of NCP infection, medical evidence, and clinical and management experience, the author formulates prevention and control management strategy of the author's unit in order to provide reference for prevention and control of burn and wound care ward."],"journal":"Zhonghua Shao Shang Za Zhi","authors":["Li, N","Liu, T M","Chen, H L","Liao, J M"],"date":"2020-02-21T11:00:00Z","year":2020,"_id":"32077677","source":"PubMed","week":"20208|Feb 17 - Feb 23","doi":"10.3760/cma.j.cn501120-20200210-00050","keywords":["burns","epidemic prevention and control","novel coronavirus pneumonia","patients' rooms"],"topics":["Prevention"],"weight":1,"_version_":1666138492955000832,"score":194.2629}]}